Location History:
- South San Francisco, CA (US) (2022)
- Cupertino, CA (US) (2014 - 2024)
Company Filing History:
6 out of 44 
5 out of 20 
5 out of 34 
Years Active: 2014-2025
Title: The Innovative Journey of Vivek Kumar Rajwanshi
Introduction: Vivek Kumar Rajwanshi, an accomplished inventor based in Cupertino, California, holds an impressive portfolio of 16 patents. His work primarily focuses on the field of nucleic acids, contributing to advancements in therapeutic technologies and molecular biology.
Latest Patents: Among his latest innovations are two notable patents. The first patent is centered around modified short interfering nucleic acid (siNA) molecules and their uses. This patent discloses siNA molecules that comprise modified nucleotides, which may be double-stranded and include 2'-O-methyl and 2′-fluoro nucleotides. Additionally, these siNA molecules may incorporate a phosphorylation blocker, conjugated moiety, or 5′-stabilized end cap to enhance their functionality. The second patent focuses on modified oligonucleotides featuring modifications at the 2' and/or 3′ positions, along with methods of making and using these oligonucleotides, such as applications against Hepatitis B Virus (HBV).
Career Highlights: Vivek has made significant contributions to the biotechnology sector through his work at various prestigious companies, including Alios Biopharma, Inc. and Aligos Therapeutics, Inc. His expertise and research have played a pivotal role in advancing therapies that leverage modified nucleic acids, showcasing his commitment to innovation in healthcare.
Collaborations: Throughout his career, Vivek has worked alongside esteemed colleagues, including Leonid Beigelman and David Bernard Smith. These collaborations have enhanced the development of groundbreaking technologies and have expanded the potential applications of nucleic acid-based therapies.
Conclusion: Vivek Kumar Rajwanshi is a remarkable inventor whose contributions to the field of molecular biology and therapeutics are substantial. With a growing number of patents and a commitment to innovation, he continues to pave the way for future advancements in medicine and biotechnology. His work exemplifies the spirit of invention and the transformative impact of research in the life sciences.